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Summary
During advanced AIDS tuberculosis (TB) often presents atypically with
smear-negativeandnon-cavitarydisease,yetimmunefeaturesassociatedwith
thischangearepoorlycharacterized.Weexaminedthelocalimmuneresponse
in a cohort of Tanzanian AIDS-associated TB patients who underwent bron-
choalveolar lavage. TB infection was conﬁrmed in bronchoalveolar lavage
(BAL) ﬂuid by culture, probe and polymerase chain reaction (PCR). Among
TB patients CD4 count correlated positively with the extent of cavitary
diseaseaswellasBALTBload(qPCRCT).TBpatientshadsigniﬁcantlyhigher
granulocyte–macrophage colony-stimulating factor (GM-CSF) than non-TB
patients, and those with non-cavitary TB had signiﬁcantly higher BAL inter-
ferongamma-inducibleprotein(IP-10)andinterleukin(IL)-7thanthosewith
cavities. BAL neutrophils were as prevalent as monocytes/macrophages or
epithelial cells, and immunohistochemistry revealed that neutrophils,
monocytes/macrophages, and epithelial cells were major sources of the IP-10
andIL-7.Thesedatasuggestadysregulatedcytokineproﬁlemaycontributeto
the TB of advanced AIDS.
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Introduction
Mycobacterium tuberculosis is the world’s most deadly bac-
terial pathogen [1]. Tuberculosis (TB) rates and mortality
are higher in HIV infected individuals [2] and TB accelerates
HIV replication and heterogeneity [3,4]. The tendency for
TB to present atypically during AIDS, without the hallmark
of upper lobe cavitary lung disease, is well established [5–8].
A proposed explanation for the lack of lung cavitation with
advanced AIDS is the loss of a CD4-mediated interferon
(IFN)-g or delayed-type hypersensitivity (DTH) response to
drive the granuloma and cavitation process [9,10]. Unfortu-
nately, supporting data that evaluate the cytokine proﬁle
from AIDS-associated TB patients are few, particularly from
the bronchoalveolar compartment, and particularly from
sub-Saharan Africa where the disease burden is highest. We
therefore sought to examine the immune characteristics of
AIDS patients with well-documented TB infection across a
range of CD4 counts and radiographic presentations.
Materials and methods
Patient population and bronchoscopy
Informedconsentwasobtainedfromallparticipantsandthe
UniversityofVirginia(UVA)HumanInvestigationCommit-
tee and the Kilimanjaro Christian Medical Centre (KCMC)
Ethics Committee reviewed and approved the project.Bron-
choscopy with bronchoalveolar lavage was performed by
standard procedure using a ﬂexible ﬁbreoptic bronchoscope
(Olympus p45,Tokyo,Japan) wedged into involved segmen-
talbronchi.Inthecaseof diffuselunginvolvement,thescope
was wedged into one of the segmental bronchi of the right
middle lobe.
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Each bronchoalveolar lavage (BAL) ﬂuid was assayed by
acid-fast bacilli (AFB) smear (at KCMC), culture (2 ml on
solid and liquid media at UVA), polymerase chain reaction
(PCR) (at UVA, see below) and by Ziehl–Neelsen stain of
BAL cell block (at UVA,see below).TB infection was deﬁned
by positive culture with conﬁrmation of M. tuberculosis
complex by DNA probe (n = 13). The TB-negative group
(n = 21) was deﬁned as AFB smear, culture and PCR
negativity.Eightpatientswereexcludedfromfurtheranalysis
because their TB status was uncertain (ﬁve were smear-
positive but culture-negative and PCR-negative; three were
smear-negative and culture-negative but PCR-positive).
Four patients were excluded because their BAL grew non-
tuberculous mycobacteria and we could not rule out over-
growth of TB. Among the non-TB cases, 10 had the
bronchoscopic appearance of Kaposi’s sarcoma. Other diag-
nostic tests were performed as per the attending physician’s
orders but were not revealing.
TB PCR
PCR for the IS6110 gene was performed on BAL ﬂuid using
the assay and primers of Pounder et al. [11]. Brieﬂy, 2 ml of
the BAL ﬂuid was centrifuged at 16 000 g for 5 min and
200 ml of PrepMan Ultra sample preparation reagent
(Applied Biosystems,Foster City,CA,USA) was added to the
pellet.The mixture was vortexed,boiled for 15 min and cen-
trifuged at 16 000 g for 5 min to remove cellular debris.PCR
of 5 ml of extracted DNA was performed in a total volume of
25 ml containing 12·5 ml of iQ SYBR Green Supermix
2¥ (Bio-Rad, Hercules, CA, USA), iTaq DNA polymerase
(50 U/ml), 6 mM MgCl2, 20 nM SYBR Green I, 0·5 mMo f
each primer,100 ng M.tuberculosis DNA for positive control
and water for negative control.Cycling conditions entailed 1
cycle at 95°C for 15 min followed by 40 cycles at 95°C for
10 s, 58°C for 20 s and 76°C for 20 s.
Radiographic analysis
All patients had chest radiographs (CXR) read in blinded
fashion by a radiologist (C. F. K.). CXR scores were deter-
mined as described previously [12]. The extent of cavitation
was estimated by measuring the diameter of each cavity
(mm) on CXR, assuming cavities were roughly spherical
(4/3 p r
3), and summing the volumes of all cavities.
CD4 count
CD4 count was measured using the Coulter Manual CD4
Count kit (Beckman Coulter, Hialeah, FL, USA).
Cytokine measurements
Five ml of BAL ﬂuid was added to dithiothreitol (DTT)
(0·05% ﬁnal concentration) to dissolve mucus and ﬁltered
with 0·22 mm ﬁlters (Millex GP, Millipore, Cork, Ireland).
Fluid was then concentrated in Amicon Ultra-15 ﬁlters
(10 000 MWCO; Millipore) and assayed for 22 cytokines/
chemokines using the human 22-plex cytokine kit (Upstate,
Charlottesville, VA, USA) on a Luminex-100 instrument,
accordingtothemanufacturer’sinstructions.Fortransform-
ing growth factor (TGF)-b1 quantiﬁcation, samples were
acid-activated to pH 1·5 with 1 N HCl for 60 min prior to
assay. To adjust for BAL dilution, all cytokine data were
normalized to the total protein content in the ﬂuid as deter-
mined by bicinchoninic acid (BCA) assay (Pierce, Rockford,
IL, USA).
Histology and immunohistochemistry (IHC)
Ten ml of BAL ﬂuid was stored in RNALater (Ambion,
Austin, TX, USA) at -70°C and cell blocks were made by
pelleting the material, ﬁxing in 10% formalin and embed-
ding in parafﬁn. Tissue sections were stained with haema-
toxylinandeosin,Ziehl–NeelsenandIHCwasperformedfor
inducible protein (IP)-10 and interleukin (IL)-7. All
pathology was scored blindly by a pathologist (L. M.).
For each sample a cellularity score was determined for
epithelial cells, monocytes/macrophages, lymphocytes
and neutrophils as follows: 0 = none, 1 = few, 2 = scattered,
3 = many. Ziehl–Neelsen-stained cell blocks were viewed at
1000¥ and scored for AFB positivity as follows: 0 = none,
1 = rare, 2 = few, 3 = scattered throughout. For IHC, 3-m-
thick parafﬁn sections were obtained using a Leica Micro-
tome, mounted on superfrost/PLUS glass slides and
deparafﬁnized to deionized water. Samples were incubated
overnight at 4°C using IP-10 and IL-7 antibodies (R&D
systems, Minneapolis, MN, USA), with dilutions ranging
from 5 mg/ml to 125 mg/ml. Samples were rinsed in
phosphate-buffered saline (PBS) and incubated with a
biotinylated secondary antibody for 30 min at room
temperature. Samples were then incubated with the ABC
kit (Vector, Burlingame, CA, USA) for 30 min at room
temperature, rinsed in PBS and stained with 3,3′
diaminobenzidine.
(DAB) substrate (Vector) before counterstaining.An IHC
score was determined for each cell population (epithelial
cells, monocytes/macrophages, lymphocytes and neutro-
phils) according to the following scale: 0 = weak, majority of
cells not staining; 1 = intermediate; 2 = strong, majority of
cells staining.
Statistics
Means and medians were compared using t-test and Mann–
Whitney test,respectively.Correlations were measured using
the Pearson linear correlation. All P-values are two-tailed.
Data shown are mean  standard deviation (s.d.) unless
indicated otherwise.
BAL cytokines in AIDS-associated TB
255 © 2007 The Author(s)
Journal compilation © 2007 British Society for Immunology, Clinical and Experimental Immunology, 148: 254–259Results
Utility of BAL PCR for detection of TB infection
The endoscopy unit at the KCMC is one of few centres in the
region equipped for bronchoscopy and serves as a referral
centre for patients with chest disease of unknown aetiology.
We enrolled and obtained consent from 46 such patients
known to be HIV-positive and performed TB diagnostics
and cytokine analysis on BAL. TB infection was identiﬁed in
13/46 (28%) by culture with conﬁrmation of M. tuberculosis
complex by DNA probe. Against this gold standard, BAL
PCR exhibited better sensitivity and speciﬁcity than BAL
AFB smear (100%/91% versus 54%/85%). Furthermore,
real-time PCR CT (cycle threshold) exhibited the expected
quantitative correlation with time to positive culture (CT
versus days to positivity; r = 0·68, P = 0·01) and AFB score
(CT versus AFB score; r = 0·67, P = 0·02).
CD4 count correlates with cavitary disease and
endobronchial TB burden
There were no signiﬁcant differences between the
TB-positive and TB-negative populations in terms of age,
gender, CXR score [4·8  1·4 versus 7·4  0·9, P = not sig-
niﬁcant (n.s.)] or CD4 count (194  41 versus 146  31,
P = n.s.).Among TB patients,average CD4 count was higher
in patients with cavities as detected by CXR (Fig. 1a). Addi-
tionally, CD4 count correlated positively with cavitary
volume and BAL Tb burden (qPCR CT; Fig. 1b,c).
BAL cytokine/chemokine response in AIDS-associated
TB
Scant data are available on the BAL response during AIDS-
associated TB. Most reports derive from HIV-negative TB in
developed countries and ﬁndings have been extremely vari-
able [13–15]. First, we examined the cell blocks prepared
from the BAL ﬂuid. As expected, lymphocytes were scant
(cellularity score 0·6  0·5), but we were surprised to ﬁnd a
substantialamountof neutrophils,manyof whichcontained
intracellular M. tuberculosis bacilli (Fig. 2; cellularity scores
2·1  0·9 for neutrophils, 2·3  0·7 for monocytes/
macrophages and 2·0  0·6 for epithelial cells, respectively,
P = n.s.). We next performed a broad characterization of 23
chemokines and cytokines in BAL ﬂuid using the Luminex
assay, with all cytokine data normalized for dilution against
the total protein content in the ﬂuid. The analysis showed
that the TB-positive group exhibited higher BAL
granulocyte–macrophage colony-stimulating factor (GM-
CSF) levels than TB-negative individuals (the deﬁnition of
TB-negativity required AFB smear, culture and PCR nega-
tivity; P = 0·007),while all other cytokines/chemokines were
not changed statistically (Table 1). Upon comparing the
immune proﬁle within the TB group, individuals with non-
cavitaryTBhadsigniﬁcantlyhigherBALIL-7andIP-10than
those with cavitary disease (P = 0·02). Other cytokines/
chemokines were not associated signiﬁcantly with
radiographic ﬁndings or CD4 count. Finally, immunohis-
tochemistry of BAL cell blocks revealed that IP-10 was pro-
duced by epithelial cells, monocytes/macrophages and
neutrophils but not lymphocytes (IHC positivity score
1·5  0·5, 1·6  0·5, 1·2  0·8 and 0·1  0·4, respectively;
n = 12, P = n.s. between epithelial cells, monocytes/
macrophages and neutrophils). Meanwhile, IL-7 was pro-
duced predominantly by epithelial cells and monocytes/
macrophages (IHC score 1·5  0·7 and 1·3  0·6 versus
0·7  0·6 and 0·0  0·0 for neutrophils and lymphocytes;
n = 11, P < 0·05 comparing epithelial cells and monocytes/
macrophages versus neutrophils or lymphocytes). For both
IP-10 and IL-7, the absence of lymphocyte staining may
reﬂect their paucity, given HIV infection.
Discussion
The importance of this work lies in the characterization of
the immune proﬁle at the site of infection from a substantial
number of HIV-infected,probe-conﬁrmed TB patients from
sub-Saharan Africa. Many studies from developing world
sitesperformonlysmearorculturebutnotprobeorPCRfor
conﬁrmation of M. tuberculosis complex. This would have
led to a signiﬁcant rate of erroneous assignment to both the
0
100
C
D
4
 
c
o
u
n
t
/
μ
l
200
300
400
500
0 5 10 15
*
(n = 7) (n = 6)
(a)
Cavitary volume (cm3)
0
100
200
300
400
500
P = 0·02
r = 0·69
Tb burden in BAL
(qPCR CT)
0
100
200
300
400
500
25 30 35 40
P = 0·05
r = 0·60
(b) (c)
Cavitary Tb Non-cavitary Tb
Fig. 1. Association between CD4 count, cavitary disease, and tuberculosis (TB) polymerase chain reaction (PCR) in bronchoalveolar lavage (BAL).
CD4 count of HIV+/TB
+ patients was compared (a) between those with and without cavitary ﬁndings on chest radiographs (CXR), (b) versus total
cavitary volume and (c) versus BAL PCR cycle threshold (CT). (a) Mean  s.e.; *P < 0·05 by t-test or Mann–Whitney test. Correlations used the
Pearson linear correlation.
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interleukin (IL)-7 in AIDS-associated
tuberculosis. Formalin-ﬁxed,
parafﬁn-embedded cell blocks were prepared
from bronchoalveolar lavage (BAL) ﬂuid and
immunohistochemistry performed with
anti-IP-10 and anti-IL-7 primary antibody.
Positive staining macrophages (arrows) and
neutrophils (arrowheads) are shown. No
background staining was observed without
IP-10 (lower left) or IL-7 antibody (not shown).
Ziehl–Neelsen (ZN) stain shows Mycobacterium
tuberculosis bacilli both inside neutrophils
(arrowhead) and extracellularly (arrow). All
photomicrographs come from one of the seven
patients with non-cavitary tuberculosis.
IP-10
IP-10 negative ZN
IL-7
Table 1. Comparison of bronchoalveolar lavage (BAL) cytokine/chemokines between HIV-infected patients with cavitary tuberculosis (TB), non-
cavitary TB and without tuberculosis.
Cytokine/chemokine
TB cavitary
(n = 6)
TB non-cavitary
(n = 7) P (cavitary versus non-cavitary)
Non-TB
(n = 21) P (TB versus non-TB)
IL-1a 205·3  69·6 112·9  43·4 n.s.a 143·3  33·1 n.s.
IL-1b 91·8  46·5 116·1  52·7 n.s. 93·0  24·6 n.s.
IL-2 6·3  1·5 4·6  1·4 n.s. 5·7  0·9 n.s.
IL-3 1·1  1·1 n.d.
b n.s. 1·9  1·2 n.s.
IL-4 3·7  1·2 2·9  1·2 n.s. 2·6  0·6 n.s.
IL-5 10·3  2·3 10·7  1·7 n.s. 8·8  1·0 n.s.
IL-6 73·0  23·0 306·9  94·3 n.s. 136·7  43·0 n.s.
IL-7 28·0  5·9 57·5  7·3 0·02 32·0  3·7 n.s.
IL-8 456·5  107·3 1272·2  493·7 n.s. 730·4  137·6 n.s.
IL-10 n.d.
b 5·5  4·5 n.s. 1·1  0·6 n.s.
IL-12p40 47·3  18·9 61·2  14·3 n.s. 47·3  14·1 n.s.
IL-12p70 8·0  1·8 12·9  2·8 n.s. 10·3  1·3 n.s.
IL-13 8·1  1·6 10·2  1·8 n.s. 8·7  1·1 n.s.
IL-15 4·8  2·2 7·9  3·8 n.s. 7·5  1·4 n.s.
IFN-g 354·7  203·5 59·9  16·2 n.s. 63·8  12·8 n.s.
TGF-b1 2·2  1·1
c 2·8  1·5 n.s. 1·7  0·5
c n.s.
TNF-a 25·6  20·9 10·3  5·9 n.s. 10·3  3·5 n.s.
Eotaxin 54·6  17·8 102·1  27·0 n.s. 82·0  11·9 n.s.
GM-CSF 8·1  1·6 12·9  2·2 n.s. 5·1  1·0 0·007
IP-10 350·5  203·5 1709·9  604·4 0·02 306·2  75·1 n.s.
MCP-1 42·6  13·3 117·6  39·7 n.s. 47·3  6·2 n.s.
MIP-1a 56·8  12·8 57·9  17·5 n.s. 46·7  5·0 n.s.
RANTES 37·0  4·7 64·2  14·8 n.s. 318  3·2 n.s.
Data shown as mean  s.e. pg cytokine/mg protein. an.s. = Not statistically signiﬁcant. P-values reﬂect t-test; however, all signiﬁcant P-values were
also met when comparing medians (Mann–Whitney test).
bn.d. = Not detected for any specimen.
cTransforming growth factor (TGF)-b1 data available
for only six cavitary TB specimens and 19 non-TB specimens. GM-CSF: granulocyte–macrophage colony-stimulating factor; RANTES: regulated upon
activation normal T cell expressed and secreted cytokines; IL: interleukin; IFN: interferon; TNF: tumour necrosis factor; IP: inducible protein;
MCP: monocyte chemoattractant protein; MIP: macrophage inﬂammatory protein.
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noteworthy aside, we feel that PCR directly on BAL, while
technically demanding in a resource-limited setting, has tre-
mendous advantages in terms of accuracy over smear and
rapidity over culture/probe.
ThecomparisonofcytokineresponsesbetweentheTBand
non-TB groups revealed a statistical increase in BAL
GM-CSF in the setting of TB, a ﬁnding that has not been
reported previously. One might predict that this chemokine
may exert a partially protective response, given its role in TB
containment and granuloma development in mice [16].
Whether additional exogenous GM-CSF would be therapeu-
tic in active TB is unknown: in one small study clinical
improvement was modest [17]. Potentially driven by the
increaseinGM-CSF,theBALneutrophilicresponsewesawin
these TB patients was notable, particularly given the abun-
dantbacilliwithintheneutrophils.Theroleof neutrophilsin
TB is unresolved:intracellular killing has been demonstrated
in vitro by some but not others [18,19]. In mouse models,
neutrophilsdonotaffectsurvivalbutdocontributetogranu-
lomaformation[20,21].Takentogether,wespeculatethatthe
increased GM-CSF and neutrophil response is an attempt by
the host to control TB, particularly in the setting of AIDS.
The association we found between CD4 count and cavi-
tary disease and endobronchial TB burden was not
surprising. Several studies have documented this trend
[5–8,10], supporting the hypothesis that CD4 cells contrib-
ute to the pathogenesis of cavitary disease and endobron-
chial spread. The mechanism by which this cavitation
process occurs is clearly of paramount importance to the
AIDS/TB epidemic due to its implication on TB
transmission. We therefore sought to examine the cytokine/
chemokine proﬁle between the cavitary and non-cavitary
groups.Based on limited human or mouse data we predicted
a correlation between loss of cavitation and a loss of tumour
necrosis factor (TNF)-a or interferon (IFN)-g [22–24];
however, diminution of these cytokines in the non-cavitary
group was modest and not statistically signiﬁcant. More
readilyapparentwastheassociationbetweenthelossof cavi-
tation and IL-7 and IP-10. To our knowledge, IL-7 has not
been reported in the BAL of TB patients. One could postu-
latethattheIL-7ismerelyamarkerfortheadvancedAIDSof
the non-cavitary group, given its association with CD4
decline [25]; however, IL-7 may be relevant to HIV patho-
genesis via its up-regulation of regulated upon activation
normal T cell expressed and secreted cytokines (RANTES)
(and thereby promotion X4 virus) [26]. The localization of
IL-7productionbyimmunohistochemistrytobronchialepi-
thelial cells and macrophages was not surprising, and has
been reported by others [27,28].
IP-10isanIFN-g-induciblechemokinecriticalforeffector
T cell development and trafﬁcking in mice [29].Its elevation
during TB has been reported [20,30]; however, a neutro-
philicsourcehasnotbeendescribed.Someauthorspostulate
a protective role for this chemokine [31], yet our ﬁndings of
extremely high levels in the advanced AIDS/non-cavitary
groupwouldargueagainstanunequivocallyprotectivefunc-
tion for IP-10. Indeed, given the positive effect of IFN-g on
IP-10 transcription (as well as that of IL-1a and TNF-a in
somesystems[32]),thehighIP-10/lowIFN-g/lowIL-1a/low
TNF-a pattern of the non-cavitary group was unexpected
and suggest loss of IP-10 regulation or induction by other
known mediators such as Toll-like receptor ligands [33,34].
Human data are important to direct research in experi-
mentalandanimalmodels,particularlygiventhecomplexity
of AIDS-associated TB which cannot be replicated easily.
Based upon our ﬁndings we question the role of GM-CSF
and neutrophils during AIDS-associated TB. Additionally,
the function of IL-7 on TB-speciﬁc HIV progression and of
IP-10 in T cell trafﬁcking in TB would seem to be fertile
topics for research.
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